- Home
- EE vs BHVN Comparison
EE vs BHVN Comparison
Compare EE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EE | BHVN |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EE | BHVN |
|---|---|---|
| Price | $33.23 | $9.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $39.20 | $29.08 |
| AVG Volume (30 Days) | 356.5K | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | 0.79 | ★ 26.08 |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $1,228,263,000.00 | N/A |
| Revenue This Year | $23.59 | N/A |
| Revenue Next Year | $24.37 | N/A |
| P/E Ratio | $26.40 | ★ N/A |
| Revenue Growth | ★ 44.26 | N/A |
| 52 Week Low | $21.29 | $7.48 |
| 52 Week High | $43.18 | $24.06 |
Technical Indicators
Market Signals| Indicator | EE | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 46.18 |
| Support Level | $32.35 | $9.41 |
| Resistance Level | $35.73 | $10.22 |
| Average True Range (ATR) | 1.34 | 0.63 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 29.29 | 25.74 |
Price Performance
Historical ComparisonAbout EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.